Psychedelic-assisted psychotherapy to heal and be well.
Safe, legal access is going to become increasingly available for a range of conditions, including depression, PTSD & substance use disorders.
Mental health care is broken, but it can be fixed.
We envision a world where all people are empowered to discover healing and wellness. That’s why we’re creating solutions to develop and deliver cutting-edge psychedelic-assisted psychotherapy and transform the mental health landscape.
Numinus supports access to psychedelic-assisted psychotherapy through Ketamine-Assisted Psychotherapy, Special Access & compassionate access trials.
Starting in Vancouver and expanding to Montreal, Numinus is proud to partner with practitioners in developing pathways to psychedelic-assisted psychotherapy.
We'll support access to psychedelic-assisted psychotherapy through these pathways:
Ketamine-assisted psychotherapy
Mindspace practitioners in Montreal will offer KAP to address depression.
Special Access for psilocybin & MDMA
Pending approval of regulatory change, Numinus intends to support practitioners in helping their patients navigate possible Special Access to psychedelic-assisted therapies for a range of conditions noting that this program is for patients with potentially life threatening conditions.
Compassionate access trials for psilocybin & MDMA
Numinus is undertaking two compassionate access clinical trials for psilocybin and MDMA, which will be conducted in our Vancouver clinic.
Learn more about Numinus’s Clinics here.
Transformative change is needed
971 million
People worldwide currently suffer from a mental disorder
450,000
People worldwide died from drug use in 2015
1 in 2
Canadians will be affected by mental health issues by the age of 40
4,000
Canadians die by suicide per year – almost 11 suicides per day
1 in 2
Canadians receive inadequate care when experiencing a depressive episode
1 in 5
Canadians suffer from addiction in any given year
1 in 11
Canadian adults will suffer PTSD in their lifetime
$51B
The estimated annual economic burden of mental illness in Canada
